---
schema_version: "secwatch.filing_event.v1"
accession: "0001819790-25-000003"
form_type: "8-K"
ticker: "TARS"
cik: "0001819790"
company_name: "Tarsus Pharmaceuticals, Inc."
filed_at: "2025-01-17T23:59:59+00:00"
generated_at: "2026-05-27T23:23:50.813486+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Tarsus board member Rosemary Crane resigns, becomes consultant; committee changes

## Summary
- Rosemary Crane resigned from Board and committees effective Jan 17, 2025; not due to any disagreement.
- Crane entered a 6-month consulting agreement with Tarsus, continuing to vest in equity awards.
- Wendy Yarno appointed Chairperson of Commercial Committee; steps off Audit Committee effective Jan 17.
- Andrew Goldberg, M.D. appointed to Audit Committee effective Jan 17, 2025.

## SEC filing metadata
- accession: 0001819790-25-000003
- form_type: 8-K
- ticker: TARS
- cik: 0001819790
- company_name: Tarsus Pharmaceuticals, Inc.
- filed_at: 2025-01-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819790/000181979025000003/0001819790-25-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819790/000181979025000003/tars-20250115.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001819790-25-000003
- JSON: https://secwatch.observer/filing/0001819790-25-000003.json
- Plain text: https://secwatch.observer/filing/0001819790-25-000003.txt

## Key facts
- Executive change
  Rosemary Crane resigned as Director at Tarsus Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Director
  source text: On January 15, 2025, Rosemary Crane, a member of the Board of Directors (the “Board”) of Tarsus Pharmaceuticals, Inc. (the “Company”) notified the Company of her resignation as a member of the Board and any committees of the Board, effective January 17, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819790/000181979025000003/0001819790-25-000003-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.